The NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
From cardiovascular health to cancer screening, these are the research stories that made headlines over the last year.
Clarissa Hsu, PhD, asked parents why they decline or delay vaccinating their children.
The investigational vaccine is in the third phase of trials and targets flu strains expected to circulate this winter.
KPWHRI researchers analyzed data from more than 640,000 vaccine doses to understand risk of severe reactions.
KPWHRI receives $10 million to continue vaccine effectiveness research for flu, COVID-19, and other respiratory diseases
Encouraging immune-response and safety data emerge from preliminary human test of genetically attenuated parasite vaccine.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.